The effects of atenolol and propranolol upon lipolysis

Br J Clin Pharmacol. 1978 Feb;5(2):123-5. doi: 10.1111/j.1365-2125.1978.tb01611.x.

Abstract

1 The effects of selective and non-selective beta-adrenoceptor blockade upon plasma non-esterified fatty acid concentrations in the fasting state and following insulin stress have been studied in normal subjects. 2 Atenolol, propranolol and placebo were compared in a double-blind cross-over trial in eight normal subjects. 3 Atenolol and propranolol significantly lowered plasma non-esterified fatty acid concentrations by a similar degree in the fasting, non-stressed state. This finding suggests that beta1-adrenoceptors are involved in the control of basal lipolysis. 4 Following insulin-induced stress, lower plasma non-esterified fatty acid concentrations were observed with propranolol than with atenolol. This difference may be due to beta2-adrenoceptor involvement in the stress mechanisms controlling lipolysis, or to the differences in the water-lipid solubility properties of these drugs.

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Atenolol / pharmacology*
  • Blood Glucose / metabolism
  • Clinical Trials as Topic
  • Double-Blind Method
  • Fasting
  • Fatty Acids, Nonesterified / blood*
  • Female
  • Humans
  • Insulin / pharmacology
  • Male
  • Placebos
  • Propanolamines / pharmacology*
  • Propranolol / pharmacology*

Substances

  • Blood Glucose
  • Fatty Acids, Nonesterified
  • Insulin
  • Placebos
  • Propanolamines
  • Atenolol
  • Propranolol